Cara Therapeutics Inc (NASDAQ:CARA)
| 15.86 Delayed Data As of May 29 |  -0.38 / -2.34%Today’s Change | 8.88 Today|||52-Week Range 27.55 | -1.55% Year-to-Date |
Latest CARA News | Press Releases
No recent news for Cara Therapeutics Inc.
Today’s Trading
| Previous close | 16.24 |
| Today’s open | 16.36 |
| Day’s range | 15.49 - 16.50 |
| Volume | 44,031 |
| Average volume (3 months) | 539,700 |
| Market cap | $770.7M |
Data as of 3:59pm ET, 05/29/2020
Growth & Valuation
| Earnings growth (last year) | -20.90% |
| Earnings growth (this year) | -5.27% |
| Earnings growth (next 5 years) | -1,161.68% |
| Revenue growth (last year) | +47.64% |
| P/E ratio | NM |
| Price/Sales | 34.57 |
| Price/Book | 4.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVROAVROBIO Inc | +1.10 | +5.74% |
| KDMNKadmon Holdings Inc | -0.03 | -0.67% |
| MTEMMolecular Templates ... | +0.07 | +0.45% |
| CUECue Biopharma Inc | +0.32 | +1.18% |
Data as of 4:31pm ET, 05/29/2020
Financials
| Next reporting date | July 30, 2020 |
| EPS forecast (this quarter) | -$0.67 |
| Annual revenue (last year) | $19.9M |
| Annual profit (last year) | -$106.4M |
| Net profit margin | -534.91% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stamford, Connecticut |
Forecasts
